AMAG

AMAG Pharmaceuticals, Inc. News Headlines

$42.68
*  
0.34
0.79%
Get AMAG Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading AMAG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
AVEO Gains on Tivozanib Agreement with Ophthotech - Analyst Blog
11/13/2014 5:20:00 PM - Zacks.com


AstraZeneca/Amgen's Brodalumab Positive in Psoriasis Trial - Analyst Blog
11/13/2014 5:10:00 PM - Zacks.com


Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape
11/13/2014 8:34:00 AM - Zacks.com


Alnylam Adds Hepatic Infectious Disease Drugs to Pipeline - Analyst Blog
11/12/2014 5:40:00 PM - Zacks.com


Achillion Jumps on Encouraging Data on its HCV Candidate - Analyst Blog
11/11/2014 5:10:00 PM - Zacks.com


Orexigen Turns Around with Q3 Earnings Beat, Shares Soar - Analyst Blog
11/11/2014 11:20:00 AM - Zacks.com


Orexigen (OREX) Worth Watching: Stock Soars 33.3% - Tale of the Tape
11/11/2014 9:25:00 AM - Zacks.com


PDL BioPharma's Q3 Earnings and Revenues Increase Y/Y - Analyst Blog
11/11/2014 9:20:00 AM - Zacks.com


Osiris Therapeutics Beats on Q3 Earnings & Revenues - Analyst Blog
11/11/2014 9:00:00 AM - Zacks.com


Repros Soars on Positive FDA Meeting Regarding Androxa - Analyst Blog
11/10/2014 5:20:00 PM - Zacks.com


Theravance Biopharma Q3 Loss Widens Y/Y, Revenues Beat - Analyst Blog
11/10/2014 11:20:00 AM - Zacks.com


Keryx (KERX) in Focus: Stock Adds 11.9% in Session - Tale of the Tape
11/7/2014 9:46:00 AM - Zacks.com


VIVUS Posts Narrower-than-Expected Q3 Loss, Revenues Up - Analyst Blog
11/6/2014 4:45:00 PM - Zacks.com


Myriad Genetics Down on Earnings, Revenue Miss in Q1 - Analyst Blog
11/6/2014 3:30:00 PM - Zacks.com


Celldex Falls with Pipeline Update Overshadowing Q3 Results - Analyst Blog
11/6/2014 2:57:00 PM - Zacks.com


Genomic Health Q3 Loss Narrower than Expected, Revenues Lag - Analyst Blog
11/6/2014 2:50:00 PM - Zacks.com


Alnylam's Q3 Loss Narrower than Expected, Pipeline in Focus - Analyst Blog
11/6/2014 12:40:00 PM - Zacks.com


Jazz Pharmaceuticals Q3 Earnings Rise Y/Y, Lifts Guidance - Analyst Blog
11/5/2014 2:20:00 PM - Zacks.com


Pharmacyclics Tops Q3 Earnings, Ties Up with AstraZeneca - Analyst Blog
11/5/2014 12:00:00 PM - Zacks.com


Cytokinetics, Incorporated (CYTK) in Focus: Stock Surges 16.2% - Tale of the Tape
11/5/2014 9:18:05 AM - Zacks.com


Achillion Pharmaceuticals Slumps: ACHN Plunges 15.6% in Session - Tale of the Tape
11/5/2014 8:34:00 AM - Zacks.com


Regeneron Q3 Earnings Up Y/Y, Narrows Eylea Guidance - Analyst Blog
11/4/2014 4:30:00 PM - Zacks.com


MannKind Falls on Missing Q3 Estimates Yet Cuts Loss Y/Y - Analyst Blog
11/4/2014 12:40:00 PM - Zacks.com


Integra Beats Earnings, Sales Up Y/Y, Outlook Lowered - Analyst Blog
11/4/2014 11:20:00 AM - Zacks.com


Arena Pharmaceuticals Posts In Line Q3 Loss, Belviq Grows - Analyst Blog
11/4/2014 9:30:00 AM - Zacks.com